• Online Features  This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (35)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Cataracts/ Lens  • Diabetic Retinopathy  • Glaucoma  • Ophthalmological Disorders, Other  • Public Health  • Public Health, Other  • Endocrine Diseases  • Diabetes Mellitus  • Alert me on articles by topic  Social Bookmarking   What's this?

United States, 2005-2050

Jinan B. Saaddine, MD, MPH; Amanda A. Honeycutt, PhD; K. M. Venkat Narayan, MD, MBA; Xinzhi Zhang, MD, PhD; Ron Klein, MD, MPH; James P. Boyle, PhD

Arch Ophthalmol. 2008;126(12):1740-1747.

Objectives  To estimate the number of people with diabetic retinopathy (DR), vision-threatening DR (VTDR), glaucoma, and cataracts among Americans 40 years or older with diagnosed diabetes mellitus for the years 2005-2050.

Methods  Using published prevalence data of DR, VTDR, glaucoma, and cataracts and data from the National Health Interview Survey and the US Census Bureau, we projected the number of Americans with diabetes with these eye conditions.

Results  The number of Americans 40 years or older with DR and VTDR will triple in 2050, from 5.5 million in 2005 to 16.0 million for DR and from 1.2 million in 2005 to 3.4 million for VTDR. Increases among those 65 years or older will be more pronounced (2.5 million to 9.9 million for DR and 0.5 million to 1.9 million for VTDR). The number of cataract cases among whites and blacks 40 years or older with diabetes will likely increase 235% by 2050, and the number of glaucoma cases among Hispanics with diabetes 65 years or older will increase 12-fold.

Conclusion  Future increases in the number of Americans with diabetes will likely lead to significant increases in the number with DR, glaucoma, and cataracts. Our projections may help policy makers anticipate future demands for health care resources and possibly guide the development of targeted interventions.

Clinical Relevance  Efforts to prevent diabetes and to optimally manage diabetes and its complications are needed.

Author Affiliations: Division of Diabetes Translation/Vision Health Initiative, Centers for Disease Control and Prevention, Atlanta, Georgia (Drs Saaddine, Narayan, Zhang, and Boyle); Research Triangle Institute International, Research Triangle Park, South Carolina (Dr Honeycutt); and Department of Ophthalmology and Visual Sciences, University of Wisconsin Medical School, Madison (Dr Klein).

CiteULike    Connotea    Delicious    Digg    Facebook    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Self-Reported Visual Impairment Among Persons With Diagnosed Diabetes--United States, 1997-2010
JAMA 2012;307:25-27.
FULL TEXT  

Predictors of Diabetic Retinopathy in a Community Health Center Population
Olayiwola et al.
Diabetes Spectr. 2011;24:218-223.
ABSTRACT | FULL TEXT  

Racial Differences in the Prevalence of Diabetes but Not Diabetic Retinopathy in a Multi-ethnic Asian Population
Chiang et al.
IOVS 2011;52:7586-7592.
ABSTRACT | FULL TEXT  

Benefits of Renin-Angiotensin Blockade on Retinopathy in Type 1 Diabetes Vary With Glycemic Control
Harindhanavudhi et al.
Diabetes Care 2011;34:1838-1842.
ABSTRACT | FULL TEXT  

13.5.2 Diabetic retinopathy
Guly et al.
Oxford Textbook of Endocrinology and Diabetes 2011;2:med-9780199235292-chapter-med-9780199235292-chapter.
ABSTRACT | FULL TEXT  

Incidence of Blindness and Severe Visual Impairment in Germany: Projections for 2030
Finger et al.
IOVS 2011;52:4381-4389.
ABSTRACT | FULL TEXT  

Diabetic Retinopathy in 2011: Further Insights From New Epidemiological Studies and Clinical Trials
Lamoureux and Wong
Diabetes Care 2011;34:1066-1067.
FULL TEXT  

The Burgeoning Public Health Impact of Diabetes: The Role of the Ophthalmologist
Beck
Arch Ophthalmol 2011;129:225-229.
ABSTRACT | FULL TEXT  

An Integrated Approach to Diabetic Retinopathy Research
Gardner et al.
Arch Ophthalmol 2011;129:230-235.
ABSTRACT | FULL TEXT  

Intravitreal Injection of Exendin-4 Analogue Protects Retinal Cells in Early Diabetic Rats
Zhang et al.
IOVS 2011;52:278-285.
ABSTRACT | FULL TEXT  

Ophthalmology Patient Knowledge of Personal and Recommended ABCs of Diabetes Care
Duncan et al.
Arch Ophthalmol 2010;128:1495-1496.
FULL TEXT  

Ablation of 4E-BP1/2 Prevents Hyperglycemia-Mediated Induction of VEGF Expression in the Rodent Retina and in Muller Cells in Culture
Schrufer et al.
Diabetes 2010;59:2107-2116.
ABSTRACT | FULL TEXT  

Prevalence of Diabetic Retinopathy in the United States, 2005-2008
Zhang et al.
JAMA 2010;304:649-656.
ABSTRACT | FULL TEXT  

The global burden of diabetes and its complications: an emerging pandemic
Susan van et al.
European Journal of Cardiovascular Prevention & Rehabilitation 2010;17:s3-s8.
ABSTRACT | FULL TEXT  

Diabetes and Obesity: A Challenge for Every Ophthalmologist
Gardner and Gabbay
Arch Ophthalmol 2009;127:328-329.
FULL TEXT